Lundåsen Thomas, Liao Wei, Angelin Bo, Rudling Mats
Metabolism Unit, Center for Metabolism and Endocrinology, Department of Medicine and Molecular Nutrition Unit, Center for Nutrition and Toxicology, Novum, Karolinska Institutet at Huddinge University Hospital, S-141 86 Stockholm, Sweden.
J Biol Chem. 2003 Oct 31;278(44):43224-8. doi: 10.1074/jbc.M302645200. Epub 2003 Aug 13.
Cholesterol elimination from the body involves reverse cholesterol transport from peripheral tissues in which the elimination of high density lipoprotein (HDL) and low density lipoprotein (LDL) cholesterol by the liver and subsequent biliary excretion as free cholesterol and bile acids are important. In situations of peripheral fat and cholesterol accumulation, such as obesity, these pathways may be overloaded, contributing to increased cholesterol deposition. Leptin has an important role in obesity, suppressing food intake and increasing energy expenditure. This hormone, which is absent in genetically obese ob/ob mice, is also thought to be involved in the coordination of lipid excretion pathways, although available data are somewhat inconsistent. We therefore studied the expression of the hepatic HDL receptor, scavenger receptor class B type I (SR-BI), and the LDL receptor as well as the rate-limiting enzyme in bile acid synthesis, cholesterol 7alpha-hydroxylase (Cyp7a1), in leptin-deficient ob/ob mice and their wild-type controls. In ob/ob mice, protein levels of both LDL receptor and SR-BI were reduced, whereas LDL receptor mRNA levels were increased and those of SR-BI were reduced, regardless of challenge with a 2% cholesterol diet. In ob/ob mice, the enzymatic activity and mRNA for Cyp7a1 were reduced, and the increase in response to dietary cholesterol was blunted. Upon short-term (2 days) treatment with leptin, a dose-dependent increase was seen in the SR-BI protein and mRNA, whereas the Cyp7a1 protein and mRNA were reduced. Our findings indicate that leptin is an important regulator of hepatic SR-BI expression and, thus, HDL cholesterol levels, whereas it does not stimulate Cyp7a1 and bile acid synthesis.
体内胆固醇的清除涉及胆固醇从外周组织的逆向转运,其中肝脏对高密度脂蛋白(HDL)和低密度脂蛋白(LDL)胆固醇的清除以及随后以游离胆固醇和胆汁酸形式的胆汁排泄非常重要。在周围脂肪和胆固醇积累的情况下,如肥胖,这些途径可能会过载,导致胆固醇沉积增加。瘦素在肥胖中起重要作用,可抑制食物摄入并增加能量消耗。这种激素在基因肥胖的ob/ob小鼠中不存在,尽管现有数据有些不一致,但也被认为参与脂质排泄途径的协调。因此,我们研究了瘦素缺乏的ob/ob小鼠及其野生型对照中肝脏HDL受体、B类I型清道夫受体(SR-BI)和LDL受体的表达,以及胆汁酸合成中的限速酶胆固醇7α-羟化酶(Cyp7a1)。在ob/ob小鼠中,无论是否用2%胆固醇饮食进行刺激,LDL受体和SR-BI的蛋白质水平均降低,而LDL受体mRNA水平升高,SR-BI的mRNA水平降低。在ob/ob小鼠中,Cyp7a1的酶活性和mRNA降低,对饮食胆固醇的反应性增加减弱。短期(2天)用瘦素治疗后,SR-BI蛋白和mRNA呈剂量依赖性增加,而Cyp7a1蛋白和mRNA减少。我们的研究结果表明,瘦素是肝脏SR-BI表达的重要调节因子,因此也是HDL胆固醇水平的重要调节因子,而它不刺激Cyp7a1和胆汁酸合成。